H. Lundbeck A/S
H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat maj… Read more
H. Lundbeck A/S (HLBBF) - Total Assets
Latest total assets as of December 2025: $53.89 Billion USD
Based on the latest financial reports, H. Lundbeck A/S (HLBBF) holds total assets worth $53.89 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
H. Lundbeck A/S - Total Assets Trend (2004–2025)
This chart illustrates how H. Lundbeck A/S’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
H. Lundbeck A/S - Asset Composition Analysis
Current Asset Composition (December 2025)
H. Lundbeck A/S's total assets of $53.89 Billion consist of 23.7% current assets and 76.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 6.4% |
| Accounts Receivable | $4.54 Billion | 8.4% |
| Inventory | $4.46 Billion | 8.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $28.71 Billion | 53.3% |
| Goodwill | $6.99 Billion | 13.0% |
Asset Composition Trend (2004–2025)
This chart illustrates how H. Lundbeck A/S's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: H. Lundbeck A/S's current assets represent 23.7% of total assets in 2025, a decrease from 51.7% in 2004.
- Cash Position: Cash and equivalents constituted 6.4% of total assets in 2025, down from 25.2% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 65.0% of total assets, an increase from 14.0% in 2004.
- Asset Diversification: The largest asset category is intangible assets at 53.3% of total assets.
H. Lundbeck A/S Competitors by Total Assets
Key competitors of H. Lundbeck A/S based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp Preferred
KO:000105
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
|
Yuyu Pharma
KO:000220
|
Korea | ₩202.42 Billion |
|
Ildong Holdings Co Ltd
KO:000230
|
Korea | ₩813.62 Billion |
H. Lundbeck A/S - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - H. Lundbeck A/S generates 0.45x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, H. Lundbeck A/S generates $5.91 in net profit.
H. Lundbeck A/S - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.44 | 1.52 | 1.02 |
| Quick Ratio | 0.94 | 1.05 | 0.69 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $3.92 Billion | $ 4.43 Billion | $ 143.00 Million |
H. Lundbeck A/S - Advanced Valuation Insights
This section examines the relationship between H. Lundbeck A/S's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.59 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -5.4% |
| Total Assets | $53.89 Billion |
| Market Capitalization | $1.48 Billion USD |
Valuation Analysis
Below Book Valuation: The market values H. Lundbeck A/S's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: H. Lundbeck A/S's assets decreased by 5.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for H. Lundbeck A/S (2004–2025)
The table below shows the annual total assets of H. Lundbeck A/S from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $53.89 Billion | -5.42% |
| 2024-12-31 | $56.98 Billion | +52.31% |
| 2023-12-31 | $37.41 Billion | -0.12% |
| 2022-12-31 | $37.45 Billion | +8.08% |
| 2021-12-31 | $34.65 Billion | -3.82% |
| 2020-12-31 | $36.03 Billion | +0.76% |
| 2019-12-31 | $35.76 Billion | +55.39% |
| 2018-12-31 | $23.01 Billion | +16.48% |
| 2017-12-31 | $19.76 Billion | -2.25% |
| 2016-12-31 | $20.21 Billion | -5.23% |
| 2015-12-31 | $21.32 Billion | -16.82% |
| 2014-12-31 | $25.64 Billion | +8.41% |
| 2013-12-31 | $23.65 Billion | +9.67% |
| 2012-12-31 | $21.56 Billion | +5.01% |
| 2011-12-31 | $20.53 Billion | +14.05% |
| 2010-12-31 | $18.00 Billion | +5.13% |
| 2009-12-31 | $17.13 Billion | +35.86% |
| 2008-12-31 | $12.61 Billion | +2.28% |
| 2007-12-31 | $12.33 Billion | +5.98% |
| 2006-12-31 | $11.63 Billion | +0.02% |
| 2005-12-31 | $11.63 Billion | +1.04% |
| 2004-12-31 | $11.51 Billion | -- |